Direkt zum Inhalt
Merck
  • BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.

BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.

Development (Cambridge, England) (2013-02-15)
Reema B Davis, Carol D Curtis, Courtney T Griffin
ZUSAMMENFASSUNG

Arteries and veins acquire distinct molecular identities prior to the onset of embryonic blood circulation, and their specification is crucial for vascular development. The transcription factor COUP-TFII currently functions at the top of a signaling pathway governing venous fate. It promotes venous identity by inhibiting Notch signaling and subsequent arterialization of endothelial cells, yet nothing is known about what regulates COUP-TFII expression in veins. We now report that the chromatin-remodeling enzyme BRG1 promotes COUP-TFII expression in venous endothelial cells during murine embryonic development. Conditional deletion of Brg1 from vascular endothelial cells resulted in downregulated COUP-TFII expression and aberrant expression of arterial markers on veins. BRG1 promotes COUP-TFII expression by binding conserved regulatory elements within the COUP-TFII promoter and remodeling chromatin to make the promoter accessible to transcriptional machinery. This study provides the first description of a factor promoting COUP-TFII expression in vascular endothelium and highlights a novel role for chromatin remodeling in venous specification.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Monoklonaler Anti-Aktin, α-Glattmuskel - Cy3 Maus-Antikörper, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
Anti-SNF2β/BRG1 Antibody, serum, Upstate®
Sigma-Aldrich
ChIPAb+ Histone H3 (CT) - ChIP Validated Antibody and Primer Set, rabbit monoclonal, culture supernatant, from rabbit